Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Weidner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 15, 2020
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trialDavid Krug, Reinhard Vonthein, Andreas Schreiber, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2020
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)Juliane Hörner-Rieber, Tobias Forster, Adriane Hommertgen, et al.
Journal of the National Cancer Institute|July 28, 2021
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925Philip M Poortmans, Henk Struikmans, Peter De Brouwer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2023
Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III TrialTobias Forster, Clara Köhler, Melissa Dorn, et al.
The New England Journal of Medicine|July 23, 2015
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerPhilip M Poortmans, Sandra Collette, Carine Kirkove, et al.
The Lancet. Oncology|November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trialPhilip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapiesOrit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
CA: a Cancer Journal for Clinicians|May 16, 2026
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
The Lancet. Oncology|June 29, 2026
Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 15, 2020
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trialDavid Krug, Reinhard Vonthein, Andreas Schreiber, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2020
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)Juliane Hörner-Rieber, Tobias Forster, Adriane Hommertgen, et al.
Journal of the National Cancer Institute|July 28, 2021
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925Philip M Poortmans, Henk Struikmans, Peter De Brouwer, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2023
Noninferiority of Local Control and Comparable Toxicity of Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Breast Cancer: 5-Year Results of the IMRT-MC2 Phase III TrialTobias Forster, Clara Köhler, Melissa Dorn, et al.
The New England Journal of Medicine|July 23, 2015
Internal Mammary and Medial Supraclavicular Irradiation in Breast CancerPhilip M Poortmans, Sandra Collette, Carine Kirkove, et al.
The Lancet. Oncology|November 5, 2020
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trialPhilip M Poortmans, Caroline Weltens, Catherine Fortpied, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 28, 2024
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapiesOrit Kaidar-Person, Liesbeth J Boersma, Peter De Brouwer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
CA: a Cancer Journal for Clinicians|May 16, 2026
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
The Lancet. Oncology|June 29, 2026
Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
Pageof 2